WHY Japan?

1. Japan = World's 2nd largest Pharmaceutical Industry

Following USA, Japan has its stable presence as the World’s 2nd largest pharmaceutical industry. And due to the increase in Japan’s aging population, the industry is expected to show further growth.

2. The Japanese government is focusing on pharma-biotech-medical research as a national strategy.

3. Strong need of international innovation

To further develop new drugs, a wider and higher-level technology combination is required. Therefore, Open Innovation is becoming popular on a world-wide basis, Japanese pharma companies are increasing, collaboration with institutions and biotech firms. However, there are very few biotech firms in Japan. Japan needs to rely on international innovation !
Your huge business opportunity!

why exhibit at Tokyo Life Science World?

1. Having the 2 shows co-held, it generates new business and research interaction!

Gathering 650 exhibitors, 15,000 visitors and 250 presentations, Life Science World will create a synergetic effect leading to new business generation.

2. Int'l companies choose PHARCON/BIOtech Japan to expand and strengthen their business in Japan!

As Asia's leading bio-pharma event, there is no reason not to choose this as a strategy base to expand and strengthen your business in Japan. In 2018, international exhibitors from 27 countries joined the event 

3. Find and collaborate with Japanese distributors

The Japanese biotech/pharma industry establishes a very unique sales structure. It is important to understand and tackle this strategically

 

Visitor Profile for Tokyo Life Science World 2018:

• - Researchers from Pharmaceutical Manufacturers
• - Drug Discovery, Research, Development, Research Planning in Pharmaceutical Manufacturers
• - Researchers from Biotech Companies
• - Researchers from Universities, Research Institutes
• - Researchers from Cosmetics, Food, Medical Device Manufacturers
• - Trading Companies, Distributors

For further information, please click here .